BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11282264)

  • 1. Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children.
    Ioannidou S; Tassios PT; Kotsovili-Tseleni A; Foustoukou M; Legakis NJ; Vatopoulos A
    Int J Antimicrob Agents; 2001 Mar; 17(3):195-201. PubMed ID: 11282264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients.
    Alcaide F; Carratala J; Liñares J; Gudiol F; Martin R
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2117-20. PubMed ID: 8878591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility of viridans group streptococci.
    Tuohy M; Washington JA
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):277-80. PubMed ID: 9458986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic susceptibility of alpha- and nonhemolytic streptococci from patients and healthy adults to 24 antimicrobial drugs.
    Traub WH; Leonhard B
    Chemotherapy; 1997; 43(2):123-31. PubMed ID: 9084921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phenotypes of macrolide, lincosamide, and streptogramin resistant Streptococcus viridans isolated from blood].
    Rodríguez-Avial C; García MM; Rodríguez-Avial I; Picazo JJ
    Rev Esp Quimioter; 1999 Dec; 12(4):346-51. PubMed ID: 10855014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci.
    Betriu C; Redondo M; Palau ML; Sánchez A; Gómez M; Culebras E; Boloix A; Picazo JJ
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1838-41. PubMed ID: 10858339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility profiles of oropharyngeal viridans group streptococci isolates from cystic fibrosis and non-cystic fibrosis patients.
    Alvarez M; Alvarez ME; Máiz L; Asensio A; Baquero F; Canton R
    Microb Drug Resist; 1998; 4(2):123-8. PubMed ID: 9650999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of erythromycin-resistant and clindamycin-susceptible (M phenotype) viridans group streptococci from pharyngeal samples: a reservoir of mef genes in commensal bacteria.
    Aracil B; Miñambres M; Oteo J; Torres C; Gómez-Garcés JL; Alós JI
    J Antimicrob Chemother; 2001 Oct; 48(4):592-4. PubMed ID: 11581247
    [No Abstract]   [Full Text] [Related]  

  • 9. Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures.
    Ergin A; Ercis S; Hasçelik G
    J Antimicrob Chemother; 2006 Jan; 57(1):139-41. PubMed ID: 16291867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora.
    Seppälä H; Haanperä M; Al-Juhaish M; Järvinen H; Jalava J; Huovinen P
    J Antimicrob Chemother; 2003 Oct; 52(4):636-44. PubMed ID: 12972451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Macrolide resistance phenotypes and genotypes in group G streptococci].
    Açikgöz ZC; Göçer S; Almayanlar E
    Mikrobiyol Bul; 2003; 37(2-3):117-24. PubMed ID: 14593892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients.
    Wisplinghoff H; Reinert RR; Cornely O; Seifert H
    J Clin Microbiol; 1999 Jun; 37(6):1876-80. PubMed ID: 10325340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominance of two M-types among erythromycin-resistant group A Streptococci from Greek children.
    Zachariadou L; Papaparaskevas J; Paraskakis I; Efstratiou A; Pangalis A; Legakis NJ; Tassios PT
    Clin Microbiol Infect; 2003 Apr; 9(4):310-4. PubMed ID: 12667242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoroquinolone resistance associated with target mutations and active efflux in oropharyngeal colonizing isolates of viridans group streptococci.
    Guerin F; Varon E; Hoï AB; Gutmann L; Podglajen I
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2197-200. PubMed ID: 10898702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phenotypic characterization of erythromycin resistance in strains of the genus Streptococcus isolated from clinical specimens].
    Limia A; Jiménez ML; Delgado T; Sánchez I; López S; López-Brea M
    Rev Esp Quimioter; 1998 Sep; 11(3):216-20. PubMed ID: 9795307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic susceptibility pattern and erythromycin resistance mechanisms in beta-hemolytic group G Streptococcus dysgalactiae subspecies equisimilis isolates from central Taiwan.
    Lo HH; Nien HH; Cheng YY; Su FY
    J Microbiol Immunol Infect; 2015 Dec; 48(6):613-7. PubMed ID: 24856419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythromycin resistance amongst group A beta-haemolytic streptococci isolated in a paediatric hospital in Athens, Greece.
    Tzelepi E; Kouppari G; Mavroidi A; Zaphiropoulou A; Tzouvelekis LS
    J Antimicrob Chemother; 1999 May; 43(5):745-6. PubMed ID: 10382903
    [No Abstract]   [Full Text] [Related]  

  • 18. Nationwide German multicenter study on the prevalence of antibiotic resistance in streptococcal blood isolates from neutropenic patients and comparative in vitro activities of quinupristin-dalfopristin and eight other antimicrobials.
    Reinert RR; von Eiff C; Kresken M; Brauers J; Hafner D; Al-Lahham A; Schorn H; Lütticken R; Peters G;
    J Clin Microbiol; 2001 May; 39(5):1928-31. PubMed ID: 11326015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis.
    Teng LJ; Hsueh PR; Chen YC; Ho SW; Luh KT
    J Antimicrob Chemother; 1998 Jun; 41(6):621-7. PubMed ID: 9687100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in-vitro activity of quinupristin/dalfopristin (RP 59500) tested against penicillin-and macrolide-resistant pneumococci by the Etest.
    Biedenbach D; Wanger A; Jones RN
    J Antimicrob Chemother; 1996 Sep; 38(3):553-5. PubMed ID: 8889731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.